Page 71 - MI-2-2

Microbes & Immunity Phylogenetic analysis of HPV16 L1 in Asia

8. Pešut E, Đukić A, Lulić L, et al. Human papillomaviruses- Papillomavirus 9-Valent Vaccine, Recombinant): Prescribing
associated cancers: An update of current knowledge. Viruses. Information [Package Insert]. US Department of Health
2021;13(11):2234. and Human Services, Food and Drug Administration;
doi: 10.3390/v13112234 2018. Available from: https://www.fda.gov/media/90064/
download [Last accessed on 2023 Nov 23].
9. El Aliani A, El Abid H, Kassal Y, et al. HPV16 L1 diversity
and its potential impact on the vaccination-induced 19. Markowitz LE, Schiller JT. Human papillomavirus vaccines.
immunity. Gene. 2020;747:144682. J Infect Dis. 2021;224:S367-S378.
doi: 10.1093/infdis/jiaa621
doi: 10.1016/j.gene.2020.144682
20. Cheng L, Wang Y, Du J. Human papillomavirus vaccines: An
10. Arroyo Mühr LS, Lagheden C, Hassan SS, Eklund C,
Dillner J. The international human papillomavirus updated review. Vaccines (Basel). 2020;8(3):391.
reference center: Standardization, collaboration, and quality doi: 10.3390/vaccines8030391
assurance in HPV research and diagnostics. J Med Virol.
2023;95(12):e29332. 21. Akhatova A, Azizan A, Atageldiyeva K, et al. Prophylactic
human papillomavirus vaccination: From the origin to the
doi: 10.1002/jmv.29332 current state. Vaccines (Basel). 2022;10:1912.

11. Cosper PF, Bradley S, Luo L, Kimple RJ. Biology of HPV doi: 10.3390/vaccines10111912
mediated carcinogenesis and tumor progression. Semin 22. Schoch CL, Ciufo S, Domrachev M, et al. NCBI taxonomy:
Radiat Oncol. 2021;31(4):265-273.
A comprehensive update on curation, resources and tools.
doi: 10.1016/j.semradonc.2021.02.006 Database (Oxford). 2020;2020:baaa062.
12. Chen XS, Garcea RL, Goldberg I, Casini G, Harrison SC. doi: 10.1093/database/baaa062
Structure of small virus-like particles assembled from the L1 23. NCBI Virus. Bethesda, MD: National Library of Medicine
protein of human papillomavirus 16. Mol Cell. 2000;5:557-567.
(US), National Center for Biotechnology Information; 2004.
doi: 10.1016/s1097-2765(00)80449-9 Available from: https://www.ncbi.nlm.nih.gov/labs/virus/
13. Liu X, Chen J, Wang Z, et al. Neutralization sites of human vssi/#/virus?viruslineage_ss=viruses,taxid:10239&seqtype_
papillomavirus-6 relate to virus attachment and entry phase s=nucleotide [Last accessed on 2024 Oct 28].
in viral infection. Emerg Microbes Infect. 2019;8:1721-1733. 24. Toparslan E, Karabağ K, Bilge U. A workflow with R:
Phylogenetic analyses and visualizations using mitochondrial
doi: 10.1080/22221751.2019.1694396
cytochrome b gene sequences. PLoS One. 2020;15(12):e0243927.
14. Mukherjee AG, Wanjari UR, Gopalakrishnan AV, et al.
Exploring the molecular pathogenesis, pathogen association, doi: 10.1371/journal.pone.0243927
and therapeutic strategies against HPV infection. Pathogens. 25. Henikoff S, Henikoff JG. Amino acid substitution
2022;12(1):25. matrices from protein blocks. Proc Natl Acad Sci U S A.
doi: 10.3390/pathogens12010025 1992;89:10915-10919.
15. Bissett SL, Godi A, Beddows S. The DE and FG loops of doi: 10.1073/pnas.89.22.10915
the HPV major capsid protein contribute to the epitopes 26. Zhou J, Doorbar J, Sun XY, Crawford LV, McLean CS,
of vaccine-induced cross-neutralizing antibodies. Sci Frazer IH. Identification of the nuclear localization signal
Rep. 2016;6:39730. of human papillomavirus type 16 L1 protein. Virology.
1991;185:625-632.
doi: 10.1038/srep39730
16. Food and Drug Administration. Cervarix (Human doi: 10.1016/0042-6822(91)90533-h
Papillomavirus Bivalent [Types 16 and 18 Vaccine, 27. Lai KY, Rizzato M, Aydin I, Villalonga-Planells R, Drexler
Recombinant): Pre-scribing Information [Package Insert]. US HCA, Schelhaas MA Ran-binding protein facilitates nuclear
Department of Health and Human Services, Food and Drug import of human papillomavirus type 16. PLoS Pathog.
Administration; 2016. Available from: https://www.fda.gov/ 2021;17(5):e1009580.
media/78013/download [Last accessed on 2023 Nov 23].
doi: 10.1371/journal.ppat.1009580
17. Food and Drug Administration. Gardasil (Human
Papillomavirus Quadrivalent [Types 6, 11, 16, and Vaccine, 28. National Center for Biotechnology Information (NCBI).
18
[Last
https://www.ncbi.nlm.nih.gov
Available
from:
Recombinant): Prescribing Information [Package Insert]. US
Department of Health and Human Services, Food and Drug accessed on 2024 Dec 08].
Administration; 2015. Available from: https://www.fda.gov/ 29. Kyte J, Doolittle RF. A simple method for displaying the
media/74350/download [Last accessed on 2023 Nov 23]. hydropathic character of a protein. J Mol Biol. 1982;157:105-132.
18. Food and Drug Administration. Gardasil 9 (Human doi: 10.1016/0022-2836(82)90515-0
Volume 2 Issue 2 (2025) 63 doi: 10.36922/mi.8410